COAGULATION-FACTOR ASSAY ABNORMALITIES IN 370 PATIENTS WITH BLOCKING INHIBITORS OF THE LUPUS TYPE (LUPUS ANTICOAGULANTS)

被引：0
|
作者：
BONTEMPO, FA
LEWIS, JH
机构：
[1] CENT BLOOD BANK PITTSBURGH,PITTSBURGH,PA
[2] UNIV PITTSBURGH,SCH MED,DEPT HEMATOL,PITTSBURGH,PA 15261
来源：
THROMBOSIS AND HAEMOSTASIS | 1993年 / 69卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1221 / 1221
页数：1
相关论文
共 50 条
  • [41] Whole blood aggregation and measurement of platelet factor 3 availability but not platelet-rich plasma aggregation studies detects platelet function abnormalities in patients with antiphospholipid syndrome, lupus anticoagulants, and prolonged bleeding times.
    Kaplan, RB
    Zeigler, ZR
    Shadduck, RK
    Lister, J
    BLOOD, 2002, 100 (11) : 690A - 691A
  • [42] Factor Xa Reactive Antibodies In Patients With Systemic LUPUS Erythematosus and Antiphospholipid Syndrome Have Differential Effects Upon Coagulation Assays and Endothelial CELLS
    Artim-Esen, Bahar
    Smoktunowicz, Natalia
    Pericleous, Charis
    Ripoll, Vera M.
    Mackie, Ian
    Chambers, Rachel
    Isenberg, David A.
    Rahman, Anisur
    Ioannou, Yiannis
    Giles, Ian
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S9 - S9
  • [43] ARTESUNATE INHIBITS TYPE I INTERFERON INDUCED PRODUCTION OF MACROPHAGE MIGRATION INHIBITORY FACTOR IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Feng, X.
    Chen, W.
    Sun, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 288 - 289
  • [44] USE OF A GENERALLY APPLICABLE TISSUE FACTOR-DEPENDENT FACTOR-V ASSAY TO DETECT ACTIVATED PROTEIN C-RESISTANT FACTOR VA IN PATIENTS RECEIVING WARFARIN AND IN PATIENTS WITH A LUPUS ANTICOAGULANT
    LE, DT
    GRIFFIN, JH
    GREENGARD, JS
    MUJUMDAR, V
    RAPAPORT, SI
    BLOOD, 1995, 85 (07) : 1704 - 1711
  • [45] Monitoring of von Willebrand factor inhibitors in patients with type 3 von Willebrand disease using a quantitative assay
    Miller, Connie H.
    HAEMOPHILIA, 2021, 27 (05) : 823 - 829
  • [46] THE PLATELET FACTOR-III ASSAY AND CIRCULATING IMMUNE-COMPLEXES AS STUDIED ON NON-THROMBOCYTOPENIC PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    KUTTI, J
    SAFAIKUTTI, S
    GOOD, RA
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1982, 29 (01): : 31 - 35
  • [47] Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus
    Feng, X.
    Chen, W.
    Xiao, L.
    Gu, F.
    Huang, J.
    Tsao, B. P.
    Sun, L.
    LUPUS, 2017, 26 (01) : 62 - 72
  • [48] A PROTHROMBIN TIME-BASED ASSAY FOR ACTIVATED PROTEIN-C (APC) RESISTANT FACTOR-V (FV) IN PATIENTS ON WARFARIN OR WITH A LUPUS ANTICOAGULANT
    LE, DT
    GRIFFIN, JH
    GREENGARD, JS
    RAPAPORT, SI
    BLOOD, 1994, 84 (10) : A84 - A84
  • [49] Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons
    Stone, Rivka C.
    Feng, Di
    Deng, Jing
    Singh, Sukhwinder
    Yang, Lisong
    Fitzgerald-Bocarsly, Patricia
    Eloranta, Maija-Leena
    Ronnblom, Lars
    Barnes, Betsy J.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (03): : 788 - 798
  • [50] Investigation of patients with unclassified bleeding disorder and abnormal thrombin generation for physiological coagulation inhibitors reveals multiple abnormalities and a subset of patients with increased tissue factor pathway inhibitor activity
    MacDonald, Stephen
    White, Danielle
    Langdown, Jon
    Downes, Kate
    Thomas, Will
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 (03) : 246 - 255
12345